Sarcoma histiocítico: presentación de un caso probable
Abstract
El sarcoma histiocítico es un desorden de células no Langerhans extremadamente raro con un curso clínico agresivo y limitadas opciones de tratamiento. Se presenta el caso de un paciente adulto joven de género masculino, con cuadro febril prolongado, compromiso hematológico persistente, hepatoesplenomegalia y linfadenopatias generalizadas con curso clínico fatal, en quien por las características clínicas, paraclínicas y de estudios histopatológicos como de inmunohistoquímica se llegó a dicha presunción diagnostica.Downloads
References
Machado ES, de Miranda AC, Escopelli T, Caron R, Escopelli AC. Histiocytic sarcoma. Rev Bras Hematol Hemoter. 2011;33(2):155-7.
Takahashi E, Nakamura S. Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop. 2013;53(1):1-8.
Brunner P, Rufle A, Dirnhofer S, Lohri A, Willi N, Cathomas G, et al. Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor. Leukemia. 014;28(9):1937-40.
Zhao J, Niu X, Wang Z, Lu H, Lin X, Lu Q. Histiocytic sarcoma combined with acute monocytic leukemia: a case report. Diagn Pathol. 2015;10:110.
Michonneau D, Kaltenbach S, Derrieux C, Trinquand A, Brouzes C, Gibault L, et al. BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia. J Clin Oncol. 2014;32(35):e117-21.
Hure MC, Elco CP, Ward D, Hutchinson L, Meng X, Dorfman DM, et al. Histiocytic sarcoma arising from clonally related mantle cell lymphoma. J Clin Oncol. 2012;30(5):e49-53.
Alvaro T, Bosch R, Salvado MT, Piris MA. True histiocytic lymphoma of the stomach associated with low-grade B-cell mucosa-associated lymphoid tissue (MALT)-type lymphoma. Am J Surg Pathol. 1996;20(11):1406-11.
Wang E, Papalas J, Hutchinson CB, Kulbacki E, Huang Q, Sebastian S, et al. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell ymphoma in a single individual. Am J Surg Pathol. 2011;35(3):457- 63.
McClure R, Khoury J, Feldman A, Ketterling R. Clonal relationship between precursor B-cell acute lymphoblastic leukemia and histiocytic sarcoma: a case report and discussion in the context of similar cases. Leuk Res. 2010;34(2):e71-3.
Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, et al. Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol. 2011;24(11):1421-32.
Mori M, Matsushita A, Takiuchi Y, Arima H, Nagano S, Shimoji S, et al. Histiocytic sarcoma and underlying chronic myelomonocytic leukemia: a proposal for the developmental classification of histiocytic sarcoma. Int J Hematol. 2010;92(1):168-73.
Song SY, Ko YH, Ahn G. Mediastinal germ cell tumor associated with histiocytic sarcoma of spleen: case report of an unusual association. Int J Surg Pathol. 2005;13(3):299-303.
Fukunaga M, Kato H. Histiocytic sarcoma associated with idiopathic myelofibrosis. Arch Pathol Lab Med. 2004;128(10):1167-70.
Mathe G, Gerard-Marchant R, Texier JL, Schlumberger JR, Berumen L, Paintrand M. The two varieties of lymphoid tissue “reticulosarcomas”, histiocytic and histioblastic types. Br J Cancer. 1970;24(4):687-95.
Durham BH, Diamond EL, Abdel-Wahab O. Histiocytic neoplasms in the era of personalized genomic medicine. Curr Opin Hematol. 2016;23(4):416-25.
Alonso-Dominguez JM, Calbacho M, Talavera M, Villalon C, Abalo L, Garcia-Gutierrez JV, et al. Cytogenetics findings in a histiocytic sarcoma case. Case Rep Hematol. 2012;2012:428279.
Cudennec CA, Johnson GR. Presence of multipotential hemopoietic cells in teratocarcinoma cultures. J Embryol Exp Morphol. 1981;61:51-9.
Dalia S, Shao H, Sagatys E, Cualing H, Sokol L. Dendritic cell and histiocytic neoplasms: biology, diagnosis, and treatment. Cancer Control. 2014;21(4):290-300.
Ansari J, Naqash AR, Munker R, El-Osta H, Master S, Cotelingam JD, et al. Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment. Eur J Haematol. 2016;97(1):9-16.
Dalia S, Jaglal M, Chervenick P, Cualing H, Sokol L. Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years. Cancers (Basel). 2014;6(4):2275-95.
Gounder M, Desai V, Kuk D, Agaram N, Arcila M, Durham B, et al. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas. Eur J Cancer. 2015;51(16):2413-22.
Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. 2004;28(9):1133-44.
Gianotti F, Caputo R. Histiocytic syndromes: a review. J Am Acad Dermatol. 1985;13(3):383-404.
Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41(1):1-29.
Heath J, Burgett S, Gaca A, Jaffe R, Wechsler D. Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy. Pediatr Blood Cancer. 2014;61(10):1874-6
Iwabuchi H, Kawashima H, Umezu H, Takachi T, Imamura M, Saitoh A, et al. Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child. Int J Hematol. 2017 Feb 28. doi: 10.1007/s12185-017-2202-8. [Epub ahead of print]
Wang H, Zhang J, Tao Q, Bian H, Shen Y, Li Y, et al. Flow cytometry used to identify histiocytic sarcoma: A case report. Cytometry B Clin Cytom. 2016;90(6):546-50.
Abidi MH, Tove I, Ibrahim RB, Maria D, Peres E. Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant. Am J Hematol. 2007;82(10):932-3.
Shukla N, Kobos R, Renaud T, Teruya-Feldstein J, Price A, McAllister- Lucas L, et al. Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab. Cancer. 2012;118(15):3719- 24.
Idbaih A, Mokhtari K, Emile JF, Galanaud D, Belaid H, de Bernard S, et al. Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib. Neurology. 2014;83(16):1478- 80.
Vaughn J, Freitag C, Hemminger J, Jones J. BRAF V600E expression in histiocytic sarcoma associated with splenic marginal zone lymphoma: a case report. J Med Case Rep. 2017 Apr 5;11(1):92.
Schlick K, Aigelsreiter A, Pichler M, Reitter S, Neumeister P, Hoefler G, et al. Histiocytic sarcoma – targeted therapy: novel therapeutic options? a series of 4 cases. Onkologie. 2012;35(7-8):447-50.
Aggarwal R, Rao S. Coexistence of tuberculosis with histiocytic sarcoma: A rare association. J Cancer Res Ther. 2015;11(3):658.
1.png)
.png){kind=logo}
